MedKoo Cat#: 581567 | Name: Deacetylmoxisylyte

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Deacetylmoxisylyte is a biochemical.

Chemical Structure

Deacetylmoxisylyte
Deacetylmoxisylyte
CAS#35231-36-8

Theoretical Analysis

MedKoo Cat#: 581567

Name: Deacetylmoxisylyte

CAS#: 35231-36-8

Chemical Formula: C14H23NO2

Exact Mass: 237.1729

Molecular Weight: 237.34

Elemental Analysis: C, 70.85; H, 9.77; N, 5.90; O, 13.48

Price and Availability

This product was removed for the commercial reasons.
Related CAS #
No Data
Synonym
Deacetylmoxisylyte; Desacetylthymoxamine
IUPAC/Chemical Name
Carvacrol, 5-(2-(dimethylamino)ethoxy)-
InChi Key
HJGRPZCEBPNMDU-UHFFFAOYSA-N
InChi Code
InChI=1S/C14H23NO2/c1-10(2)12-9-13(16)11(3)8-14(12)17-7-6-15(4)5/h8-10,16H,6-7H2,1-5H3
SMILES Code
CC(C)C1=CC(O)=C(C)C=C1OCCN(C)C
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 237.34 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Marquer C, Bressolle F. Moxisylyte: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in impotence. Fundam Clin Pharmacol. 1998;12(4):377-87. Review. PubMed PMID: 9711459. 2: Marquer C, Bressolle F. High-performance liquid chromatographic determination of the conjugate metabolites of moxisylyte in human plasma and urine. J Chromatogr B Biomed Sci Appl. 1997 Apr 11;691(2):389-96. PubMed PMID: 9174276. 3: Marquer C, Trouvin JH, Lacolle JY, Dupont C, Jacquot C. Pharmacokinetics of a prodrug thymoxamine: dose-dependence of the metabolite ratio in healthy subjects. Eur J Drug Metab Pharmacokinet. 1991 Jul-Sep;16(3):183-8. PubMed PMID: 1839981. 4: Roquebert J, Malek A, Creuzet MH, Cognie F, Pontagnier H. Alpha 1- and alpha 2-adrenoceptor selectivity of moxisylyte (thymoxamine) and its metabolites in the pithed rat. Arch Int Pharmacodyn Ther. 1983 Dec;266(2):282-93. PubMed PMID: 6320755.